Associated Papers
The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.
Labonte MJ et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2012
Select a paper to view details